KRAS and cancer: We aimed to characterize the heterogeneity of genetic variations accompanying low-frequency KRAS mutation detected in plasma ctDNA of these patients, and to evaluate the potential prognostic values of low-frequency ctDNA KRAS mutation in cancer progression and treatment responses.